close

Clinical Trials

1 2 3 210
Number of results: 4200

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2018-06-15 LentiGlobin® BB305 (autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human beta A-T87Q-globin gene) transfusion-dependent beta-thalassemia with non-Beta0/Beta0 genotypes 3 Bluebird bio (USA - MA) Rare diseases - Genetic diseases - Hematological diseases
2018-06-15 LentiGlobin® BB305 (autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human beta A-T87Q-globin gene) beta-thalassemia 1-2 bluebird bio (USA - MA) Hematologic diseases - Genetic diseases - Rare diseases
2018-05-14 ARO-HBV chronic hepatitis B virus (HBV) infection 1-2 Arrowhead Pharmaceuticals (USA - CA) Infectious diseases
2018-03-26 ALX-0061 - vobarilizumab systemic lupus erythematosus (SLE) 2 Ablynx (Belgium) AbbVie (USA -IL) Autoimmune diseases
2018-03-22 rovalpituzumab tesirine (Rova-T) relapsed or refractory delta-like protein 3 (DLL3) expressing small cell lung cancer (SCLC) 2 Stemcentrx (USA - CA), now AbbVie (USA - IL) Cancer - Oncology - Rare diseases
2018-03-03 DX-2930 - lanadelumab type 1 and type 2 hereditary angioedema (HAE) 3 Dyax (USA - MA), now Shire (UK - USA) Rare diseases - Genetic diseases - Hematological diseases
2018-02-21 CAR-Treg manufacturing process - Txcell (France) Technology - Services - Autoimmune diseases - Immunological diseases
2018-02-16 guselkumab (CNTO 1959) psoriasis 3 Janssen Research & Development, a J&J company (USA - NJ) Autoimmune diseases - Dermatological diseases
2018-02-15 Otezla® (apremilast) ulcerative colitis 2 Celgene (USA - NJ) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2018-02-15 OPRX-106 ulcerative colitis 2 Protalix BioTherapeutics (Israel) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2018-02-12 Chronocort® (hydrocortisone modified release capsules) congenital adrenal hyperplasia (CAH) 3 Diurnal Limited (UK) Rare diseases - Endocrine diseases - Hormonal diseases
2018-02-08 ABO-102 (SC AAV-SGSH) mucopolysaccharidosis type IIIA (Sanfilippo B syndrome) 1-2 Abeona Therapeutics (USA - NY) Rare diseases - Genetic diseases
2018-02-07 ABO-101 (AAV NAGLU) mucopolysaccharidosis type IIIB (MPS IIIB or Sanfilippo syndrome Type B) 1-2 Abeona Therapeutics (USA - NY) Rare diseases
2018-02-05 Rolontis™ (eflapegrastim) chemotherapy-induced neutropenia in patients with breast cancer. 3 Spectrum Pharmaceuticals (USA - NV) Cancer - Oncology - Hematological diseases
2018-01-24 Traumakine® - FP-1201 (human recombinant interferon-beta 1a) acute respiratory distress syndrome (ARDS) 1 Faron Pharmaceuticals (Finland) Lung diseases - Respiratory diseases - Rare diseases
2018-01-18 BM32 grass pollen allergy 2 Biomay (Austria) Allergic diseases
2018-01-15 Cx601 (adipose derived allogeneic stem cell therapy) perianal fistulas in Crohn's disease patients 3 Tigenix (Belgium) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2018-01-10 GS030 retinitis pigmentosa 1-2 Gensight Biologics (France) Rare diseases - Genetic diseases - Ophtalmological diseases
2018-01-08 AR101 peanut allergy 3 Aimmune Therapeutics (USA - CA) previously Allergen Research Corporation (ARC) Allergic diseases
2018-01-08 Tesomet® (tesofensine) Prader-Willi syndrome 2a Saniona (Denmark) Rare diseases - Genetic diseases - Metabolic diseases